Sinopharm Capital

Sinopharm Capital

A private equity firm in China that focuses on medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability

Sinopharm Capital is a private equity firm in China that focuses on medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. Founded 2012 in Shanghai, China, it invests in early stage companies. Its portfolio companies include ArteryFlow, Baicare, Synyi, Novena Global Healthcare Group, Suzhou and Science Technology Development, Dingdang Kuaiyao, HealthCare Biotech, Skynor Medical, Virogin Biotech, and GenFleet Therapeutics. As of February 2020, Sinopharm Capital has made 18 investments. Their most recent investment was on December 31, 2019 with ArteryFlow. Sinopharm Capital has raised a single venture fund, Sino-Singapore Healthcare Fund. This fund was announced on June 21, 2019 and raised a total of $150M.

Timeline

2012

Founded

Funded Companies

Company
Description
Industry
Website
Location
Ansun BioPharma

Ansun BioPharma is a San Diego-based company.

San Diego
Virtual Incision

Company

2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Xiaoming Yang

Managing Director

Aimin Wu

President

Fei Jiang

Executive Vice-President

Yong Kuang

Managing Director

Yunlei Gong

Vice-President

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

ArteryFlow

Baicare

Dingdang Kuaiyao

GenFleet Therapeutics

HealthCare Biotech

Novena Global Healthcare Group

Skynor Medical

Suzhou And Science Technology Development

Synyi

Virogin Biotech

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.